Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that two abstracts ...

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Liver checks are being offered at supermarkets and football matches and in offices as part of efforts to catch cancer early.

Rates of chronic liver disease during pregnancy are rising partly due to MASLD and the downward trend of chronic viral hepatitis.

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...

Statins reduce cirrhosis risk in a dose- and age-dependent manner. A daily dose equivalent to ≥20 mg simvastatin (or >40 mg for <54 years) appears effective, regardless of formulation. Independent ...

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is ...

Terry's nails, a nail abnormality characterized by a white, frosted appearance with a reddish-brown band at the tip, can ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Epidemiological data on bacterial infections in cirrhosis in China remain limited. Therefore, we aimed to conduct a multicenter study to investigate the characteristics and outcomes of patients with ...